Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
3.160
+0.100 (3.27%)
Mar 4, 2026, 2:28 PM EST - Market open
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $537.01 million as of March 4, 2026. Its market cap has increased by 91.03% in one year.
Market Cap
537.01M
Enterprise Value
377.07M
1-Year Change
91.03%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $537.01M, a decrease of -79.21%. That is a compound annual growth rate of -47.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 520.01M | 70.95% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 627.81M |
| Allogene Therapeutics | 624.75M |
| Alto Neuroscience | 611.70M |
| MeiraGTx Holdings | 608.51M |
| LB Pharmaceuticals | 607.43M |
| YD Bio | 603.34M |
| Ocugen | 596.76M |
| Design Therapeutics | 594.70M |